Syrosingopine sensitizes cancer cells to killing by metformin

We report that the anticancer activity of the widely used diabetic drug metformin is strongly potentiated by syrosingopine. Synthetic lethality elicited by combining the two drugs is synergistic and specific to transformed cells. This effect is unrelated to syrosingopine’s known role as an inhibitor...

Full description

Saved in:
Bibliographic Details
Published in:Sci Adv
Main Authors: Benjamin, Don, Colombi, Marco, Hindupur, Sravanth K., Betz, Charles, Lane, Heidi A., El-Shemerly, Mahmoud Y. M., Lu, Min, Quagliata, Luca, Terracciano, Luigi, Moes, Suzette, Sharpe, Timothy, Wodnar-Filipowicz, Aleksandra, Moroni, Christoph, Hall, Michael N.
Format: Artigo
Language:Inglês
Published: American Association for the Advancement of Science 2016
Subjects:
Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5182053/
https://ncbi.nlm.nih.gov/pubmed/28028542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.1601756
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items